Our data and recent reports that shRNA knockdown of CD47 suppressed CSCs in hepatocellular carcinoma [17] and mammospheres formation in the SUM159 breast carcinoma cell line [19] suggest that direct cell-autonomous effects of therapeutic CD47 antibodies to suppress CSC may extend to additional cancers. The gene discussed is CD47; the disease is cancer.